•
Dec 30, 2024

Tenaya Therapeutics Q4 2024 Earnings Report

Expected Revenue:$1M
Expected EPS:-$0.31
+31.1% YoY
Total Revenue
$0
Previous year: $17.7M
-100.0%
Gross Profit
-$2.09M
Previous year: $14.7M
-114.2%
Cash and Equivalents
$61.4M
Previous year: $105M
-41.3%
Free Cash Flow
-$18.6M
Previous year: -$22.3M
-16.7%
Total Assets
$123M
Previous year: $171M
-27.7%

Tenaya Therapeutics

Tenaya Therapeutics